Multiple Sclerosis and Erectile Dysfunction: Prevalence, Mechanisms, and Management
Erectile dysfunction (ED) affects 50–75% of men with multiple sclerosis (MS) at some point.
Mechanisms
- Neurogenic: Demyelination of spinal cord (T11–L2) and brainstem pathways mediating erection.
- Vascular: Endothelial dysfunction, reduced NO bioavailability.
- Medication side effects: Anticholinergics (oxybutynin), antidepressants (SSRIs), baclofen, opioids.
- Psychological: Depression, anxiety, body image, relationship strain.
- Fatigue/spasticity: Physical barriers to intimacy.
Evaluation
- Detailed sexual history, IIEF questionnaire.
- Review MS medications.
- Nocturnal penile tumescence (NPT) or penile Doppler if vascular etiology suspected.
Treatment
- PDE5 inhibitors (sildenafil, tadalafil): First-line; effective in neurogenic ED.
- Vacuum erection device: Non-pharmacologic.
- Intracavernosal injections (alprostadil): If PDE5i fail.
- Penile implant: Definitive surgical option.
- Medication adjustment: Switch offending agents.
- Psychosexual counseling: Address mood, relationship, performance anxiety.
- Pelvic floor PT: For spasticity/coordination.
Multidisciplinary approach (neurology, urology, psychology) yields best outcomes. ED is treatable; do not accept it as inevitable.
Multiple Sclerosis - Related Articles
- These Factors Can Affect Your Quality of Life with MS
- Understanding Multiple Sclerosis (MS): Symptoms, Treatment & Management
- Multiple Sclerosis (MS): Early Symptoms & What to Watch For
- Multiple Sclerosis vs. Fibromyalgia: Understanding the Differences
- Spinal Cord Lesions in Multiple Sclerosis: Symptoms, MRI Diagnosis, and Management
- Managing Pain in Multiple Sclerosis (MS): Effective Strategies
- Multiple Sclerosis (MS): Understanding Symptoms & When to Seek Help
